Jha, Roshan KumarRaut, ShristiAdhikari, MaheshRai, Junu RichhinbungShah, ChhayaKattel, Hari PrasadSharma, Sangita2025-11-042025-11-042025https://hdl.handle.net/20.500.14572/3034Roshan Kumar Jha Department of Microbiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author Shristi Raut Department of Microbiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author Mahesh Adhikari Department of Microbiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author Junu Richhinbung Rai Department of Microbiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author Chhaya Shah Department of Microbiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author Hari Prasad Kattel Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal Author Sangita Sharma Department of Microbiology, Maharajgunj Medical Campus, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal AuthorAbstract: Candida auris is a growing fungal threat that has sparked global concern. It has been linked to healthcare-related outbreaks and infections around the world and has been reported in numerous countries. This case report describes an infection caused by Candida auris in a 21-year-old patient with a prolonged hospital stay. On the 60th day of admission, the patient developed persistent fever and cerebrospinal fluid culture revealed Candida spp. Identification of the species and antimicrobial susceptibility testing was done by VITEK-2. The isolate was sensitive to flucytosine and voriconazole and resistant to fluconazole and amphotericin B. Voriconazole was started after the culture and sensitivity results.en-USCandida aurisemerging fungusmultidrug resistantArticle